| Mepha Pharma AG - Lacosamid-Mepha 150 mg, Filmtabletten | | 67630 | | 03 | | Lacosamid-Mepha 150 mg | | Filmtabletten | | N03AX18 | | | | 26.06.2021 | | |
| | Composition | | Filmtablette: lacosamidum 150 mg, cellulosum microcristallinum, hydroxypropylcellulosum, silica colloidalis anhydrica, crospovidonum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, talcum, E 110 293.265 µg, E 171, E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. | informations additionels |
|---|
| | 150 mg | Filmtablette |
| | BAG: Principe actif | Concentr. |
|---|
| | 150 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| | | | | | | | | | | | | | 293.265 µg | color. | | | | color. | | | | color. | | | | | | Macrogol | | | | | | | | | | Überzug | | | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| |
|
